Peipei Wang

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Tumor histologic subtypes and stage impact the risk of cardiovascular diseases death in lung cancer patients after chemotherapy or radiotherapy: a population-based study.

Tumor histologic subtypes and stage impact the risk of cardiovascular diseases death in lung cancer patients after chemotherapy or radiotherapy: a population-based study.

Journal: Translational cancer research
Published: February 05, 2026

HNRNPA2B1 Orchestrates Immune Evasion in Colorectal Cancer by Rewiring Tumor-Immune Cell Interactions and Suppressing CD8+ T-cell Infiltration.

HNRNPA2B1 Orchestrates Immune Evasion in Colorectal Cancer by Rewiring Tumor-Immune Cell Interactions and Suppressing CD8+ T-cell Infiltration.

Journal: Cancer immunology research
Published: April 03, 2025

AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers.

AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers.

Journal: International immunopharmacology
Published: December 04, 2024

NRI and SIRI are the optimal combinations for prognostic risk stratification in patients with non-small cell lung cancer after EGFR-TKI therapy.

NRI and SIRI are the optimal combinations for prognostic risk stratification in patients with non-small cell lung cancer after EGFR-TKI therapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 01, 2024

Immune effector dysfunction signatures predict outcomes in patients with colorectal cancer.

Immune effector dysfunction signatures predict outcomes in patients with colorectal cancer.

Journal: International immunopharmacology
Published: January 06, 2024

Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway.

Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway.

Journal: Oncogenesis
Published: November 28, 2021

Neuron specific enolase promotes tumor metastasis by activating the Wnt/β-catenin pathway in small cell lung cancer.

Neuron specific enolase promotes tumor metastasis by activating the Wnt/β-catenin pathway in small cell lung cancer.

Journal: Translational oncology
Published: November 26, 2020

IL-1β Promotes Stemness of Tumor Cells by Activating Smad/ID1 Signaling Pathway.

IL-1β Promotes Stemness of Tumor Cells by Activating Smad/ID1 Signaling Pathway.

Journal: International journal of medical sciences
Published: January 25, 2020

CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.

CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.

Journal: International journal of medical sciences
Published: October 03, 2019

lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia.

lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia.

Journal: Oncology letters
Published: October 24, 2018

MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway.

MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway.

Journal: BMC cancer
Published: September 25, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026